Search results for " biopharma" in Articles / App Notes
Article
Oligonucleotide manufacturing: how to get a strong start
Oligonucleotide therapeutics have huge potential for transforming human health. If you’re a small biotech or lab developing such therapies, playing the long game is crucial to successful in-ho…
Article
Get a strong start in oligonucleotide manufacturing
Oligonucleotide therapeutics hold incredible promise. How can you harness their full potential? When starting process development, you need to know where to focus, and you need a scalable a…
Article
Future-proof your AAV process with a complete producer cell line – just induce and grow
Stable producer cell lines helped to make mAb therapies the powerhouses they are today. To deliver on the promise of AAV-based gene therapy for prevalent diseases, we need similar technology. …
Article
Pushing the Barriers in Next-Gen Antibody Development
Continued development of new and next-generation antibodies is spurred by the increasing demand for more effective and custom-tailored biologic therapies. In particular, bispecific antibodi…
Article
BetaLife Wins Cytiva's First BioChallenge Competition in Southeast Asia
Southeast Asia BioChallenge received applications from companies with interests in four different therapeutic areas. BetaLife was named as the winner of the first BioChallenge in Southeast A…
Article
Get to know: oligonucleotide synthesis workflow
This free interactive course introduces you to synthetic oligonucleotides, applications they’re used in, and how they’re synthesized.
Take the course now
Article
Simulation gets therapies to patients faster and smarter
Digital solutions are helping to decrease therapeutic time to market but remain challenging – learn how we work on overcoming that challenge!
Read article
Article
Determining and Optimizing Dynamic Binding Capacity
Dynamic binding capacity (DBC) indicates the quantity of a specific biomolecule that can be bound during a chromatography purification step under a specific set of process conditions. Determ…
Article
eBook: Purification of Antibody Therapeutics - Approach for Diversified Pipeline
Antibody therapeutics are the largest class of biotherapeutics. Over the years, development beyond traditional monoclonal antibodies (mAbs) has increased. Today, we see multispecific and bispe…
Article
Expanding the Emerging Therapeutic Horizon
Despite the successes that have already been achieved with emerging therapy development and manufacturing, companies are still facing numerous challenges. Aspects such as demand for accelerate…